WealthManagement Magazine

Mergers & Hormones Don't Mix

You can blame your company's failed M&A attempt on hormones young, male hormones, that is.

You can blame your company's failed M&A attempt on hormones — young, male hormones, that is. According to research from Sauder School of Business, testosterone can be a negative factor in high-stakes decision making. Researchers found that young, male CEOs (who have higher levels of testosterone) tend to reject M&A offers even when it's against their interest — 20 percent more likely than their older male counterparts.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish